Ohsuzu F, Yanagida S, Sakata N, Nakamura H
Department of Internal Medicine I, National Defense Medical College, Saitama, Japan.
Jpn Circ J. 1989 Sep;53(9):1138-43. doi: 10.1253/jcj.53.1138.
The Langendorff perfused rat heart was used to investigate whether myocardial damage during ischemia and reperfusion could be protected by free radical scavengers, calcium antagonist and adenosine. Myocardial high energy phosphates were measured by phosphorus-31 NMR spectroscopy during normal perfusion, 20 min of ischemia and 20 min of reperfusion. In hearts, which were treated both with free radical scavengers (FRS) (Superoxide dismutase): 24 IU/ml and catalase 22 IU/ml) and verapamil (10(-7) M), beta-ATP was significantly higher than that of FRS at the end of ischemia. However, beta-ATP recovered only to 83% of baseline value at the end of reperfusion. In view of myocardial metabolism, verapamil treated hearts were good for recovery of creatine phosphate (PCr) but not ATP at the end of reperfusion. Hearts which were treated with only adenosine did not differ from control hearts. However, when hearts were treated with both verapamil and adenosine (10(-4) M), recovery of both ATP and PCr content was significantly greater than that of control hearts. These results suggested that pretreatment with both verapamil and adenosine before and after global ischemia could protect ischemic myocardium, but, further studies are necessary to clarify the precise mechanism of protection.
采用Langendorff灌流大鼠心脏来研究自由基清除剂、钙拮抗剂和腺苷是否能保护缺血再灌注期间的心肌损伤。在正常灌注、20分钟缺血和20分钟再灌注期间,通过磷-31核磁共振波谱法测量心肌高能磷酸盐。在用自由基清除剂(超氧化物歧化酶:24 IU/ml和过氧化氢酶22 IU/ml)和维拉帕米(10⁻⁷ M)联合处理的心脏中,缺血末期β-ATP显著高于仅用自由基清除剂处理的心脏。然而,再灌注末期β-ATP仅恢复到基线值的83%。从心肌代谢来看,维拉帕米处理的心脏在再灌注末期有利于磷酸肌酸(PCr)的恢复,但不利于ATP的恢复。仅用腺苷处理的心脏与对照心脏无差异。然而,当心脏用维拉帕米和腺苷(10⁻⁴ M)联合处理时,ATP和PCr含量的恢复均显著高于对照心脏。这些结果表明,在全心缺血前后用维拉帕米和腺苷预处理可保护缺血心肌,但需要进一步研究以阐明确切的保护机制。